Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
This is a single arm, open-label, multi-center, phase II study to determine the efficacy and safety of an experimental therapy called CTL019 T-cells in pediatric patients with B-cell acute lymphoblastic leukemia, who are chemo-refractory, relapsed after allogeneic SCT, or are otherwise ineligible for allogeneic stem cell transplant.
Inclusion criteria
- B-cell Acute Lymphoblastic Leukemia,Relapsed B-cell Acute Lymphoblastic Leukemia,Refractory B-cell Acute Lymphoblastic Leukemia